United States

Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration with Regeneron to Discover and Develop Gene Therapies for Hearing Loss

Collaboration gene therapy product candidate, DB-OTO, on track to enter clinical testing in 2022; two additional gene therapy programs for congenital, monogenic forms of hearing loss in development under the collaboration Decibel to receive $10…

Read More »

Intellia Therapeutics Announces Expansion of Ongoing Phase 1 Study of NTLA-2001 to Include Adults with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

Ayr Wellness Enters Agreement to Acquire Dispensary 33 in Chicago

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment

Degreed is named a Leader in Learning Management Systems and Experience Platforms

BioCryst Adds $350 Million in New Financing with Royalty Pharma and OMERS Capital Markets

XPO Logistics Announces Second Annual Shoe Drive to Support Soles4Souls

Concentrix Announces Acquisition of PK, a Leading Global CX Design Engineering Company

Day One Announces First Patient Dosed in Phase 2 Monotherapy Study in RAF-altered Solid Tumors

Ashland board authorizes quarterly dividend

Akouos to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference

SAB Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Company Update

Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals

Amicus Therapeutics Announces Presentations at the 14th International Congress of Inborn Errors of Metabolism

EDCare Launches Athlete EDGE­™ at EDCare, a Specialized Eating Disorder Treatment Program for High-Performance Athletes

Bitcoin Miner GRIID Secures $525M Credit Facility from Blockchain.com

Organogenesis Appoints Prathyusha Duraibabu to Board of Directors

Larimar Therapeutics to Participate in the Piper Sandler 33rd Annual Healthcare Conference

Diffusion Pharmaceuticals Doses First Participants in Altitude Trial